The mandatory role of IL-10-producing and OX40 ligand-expressing mature langerhans cells in local UVB-induced immunosuppression

Journal of Immunology

Volumn 184, Issue 10, 2010, Pages 5670-5677

  Yoshiki, Ryutaro ^a   Kabashima, Kenji ^b   Sakabe, Jun Ichi ^a   Sugita, Kazunari ^a   Bito, Toshinori ^a   Nakamura, Motonobu ^a   Malissen, Bernard ^c   Tokura, Yoshiki ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; OX40 LIGAND; TUMOR NECROSIS FACTOR ALPHA; CD207 PROTEIN, MOUSE; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; LECTIN; LIGAND; MANNOSE BINDING LECTIN; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; SIGNAL PEPTIDE; TNFSF4 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL MIGRATION; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNOSUPPRESSIVE TREATMENT; LANGERHANS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; ULTRAVIOLET B RADIATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL DIFFERENTIATION; CYTOLOGY; GENE TARGETING; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; METHODOLOGY; ORGAN CULTURE TECHNIQUE; RADIATION EXPOSURE; SKIN; ULTRAVIOLET RADIATION;

ANIMALS; ANTIGENS, SURFACE; CELL DIFFERENTIATION; FEMALE; GENE KNOCK-IN TECHNIQUES; IMMUNOSUPPRESSION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-10; LANGERHANS CELLS; LECTINS, C-TYPE; LIGANDS; LYMPHOCYTE ACTIVATION; MANNOSE-BINDING LECTINS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; ORGAN CULTURE TECHNIQUES; SKIN; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTORS; ULTRAVIOLET RAYS;

EID: 77954706659     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903254     Document Type: Article

References (63)

1. Fisher, G. J., Z. Q. Wang, S. C. Datta, J. Varani, S. Kang, and J. J. Voorhees. 1997. Pathophysiology of premature skin aging induced by ultraviolet light. N. Engl. J. Med. 337: 1419-1428.
2. Gilchrest, B. A. 1990. Actinic injury. Annu. Rev. Med. 41: 199-210.
3. Kraemer, K. H. 1997. Sunlight and skin cancer: another link revealed. Proc. Natl. Acad. Sci. USA 94: 11-14.
4. Kulms, D., and T. Schwarz. 2000. Molecular mechanisms of UV-induced apoptosis. Photodermatol. Photoimmunol. Photomed. 16: 195-201.
5. Tokura, Y. 1992. Mechanisms of local, low-dose UVB-induced immunosuppression in contact hypersensitivity. J. Dermatol. 19: 923-931.
6. Toews, G. B., P. R. Bergstresser, and J. W. Streilein. 1980. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J. Immunol. 124: 445-453.
7. Elmets, C. A., P. R. Bergstresser, R. E. Tigelaar, P. J. Wood, and J. W. Streilein. 1983. Analysis of themechanism of unresponsiveness produced by haptens painted on skin exposed to low dose ultraviolet radiation. J. Exp. Med. 158: 781-794.
8. Satoh, T., Y. Tokura, Y. Satoh, and M. Takigawa. 1990. Ultraviolet-induced suppressor T cells and factor(s) in murine contact photosensitivity. III. Mode of action of T-cell-suppressor factor(s) and interaction with cytokines. Cell. Immunol. 131: 120-131.
9. Tokura, Y., Y. Miyachi, M. Takigawa, and M. Yamada. 1987. Ultraviolet-induced suppressor T cells and factor(s) in murine contact photosensitivity. I. Biological and immunochemical characterization of factor(s) extracted from suppressor T cells. Cell. Immunol. 110: 305-320.
10. Groux, H., A. O'Garra, M. Bigler, M. Rouleau, S. Antonenko, J. E. de Vries, and M. G. Roncarolo. 1997. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742.
11. McHugh, R. S., and E. M. Shevach. 2002. The role of suppressor T cells in regulation of immune responses. J. Allergy Clin. Immunol. 110: 693-702.
12. Roncarolo, M. G., R. Bacchetta, C. Bordignon, S. Narula, and M. K. Levings. 2001. Type 1 T regulatory cells. Immunol. Rev. 182: 68-79.
13. Schwarz, A., S. Beissert, K. Grosse-Heitmeyer, M. Gunzer, J. A. Bluestone, S. Grabbe, and T. Schwarz. 2000. Evidence for functional relevance of CTLA-4 in ultraviolet-radiation-induced tolerance. J. Immunol. 165: 1824-1831.
14. Kang, K., C. Hammerberg, L. Meunier, and K. D. Cooper. 1994. CD11b+ macrophages that infiltrate human epidermis after in vivo ultraviolet exposure potently produce IL-10 and represent the major secretory source of epidermal IL-10 protein. J. Immunol. 153: 5256-5264.
15. Baum, P. R., R. B. Gayle, III, F. Ramsdell, S. Srinivasan, R. A. Sorensen, M. L. Watson, M. F. Seldin, E. Baker, G. R. Sutherland, K. N. Clifford, et al. 1994. Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34. EMBO J. 13: 3992-4001.
16. Godfrey, W. R., F. F. Fagnoni, M. A. Harara, D. Buck, and E. G. Engleman. 1994. Identification of a human OX-40 ligand, a costimulator of CD4+ T cells with homology to tumor necrosis factor. J. Exp. Med. 180: 757-762.
17. Mallett, S., S. Fossum, and A. N. Barclay. 1990. Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes-a molecule related to nerve growth factor receptor. EMBO J. 9: 1063-1068. (Pubitemid 20110569)
18. Miura, S., K. Ohtani, N. Numata, M. Niki, K. Ohbo, Y. Ina, T. Gojobori, Y. Tanaka, H. Tozawa, M. Nakamura, et al. 1991. Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax. Mol. Cell. Biol. 11: 1313-1325.
19. Paterson, D. J., W. A. Jefferies, J. R. Green, M. R. Brandon, P. Corthesy, M. Puklavec, and A. F. Williams. 1987. Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts. Mol. Immunol. 24: 1281-1290.
20. Stüber, E., M. Neurath, D. Calderhead, H. P. Fell, and W. Strober. 1995. Crosslinking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 2: 507-521.
21. Brocker, T., A. Gulbranson-Judge, S. Flynn, M. Riedinger, C. Raykundalia, and P. Lane. 1999. CD4 T cell traffic control: in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles. Eur. J. Immunol. 29: 1610-1616.
22. Ohshima, Y., Y. Tanaka, H. Tozawa, Y. Takahashi, C. Maliszewski, and G. Delespesse. 1997. Expression and function of OX40 ligand on human dendritic cells. J. Immunol. 159: 3838-3848.
23. Weinberg, A. D., K. W. Wegmann, C. Funatake, and R. H. Whitham. 1999. Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis. J. Immunol. 162: 1818-1826.
24. Imura, A., T. Hori, K. Imada, T. Ishikawa, Y. Tanaka, M. Maeda, S. Imamura, and T. Uchiyama. 1996. The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J. Exp. Med. 183: 2185-2195.
25. Ohshima, Y., L. P. Yang, T. Uchiyama, Y. Tanaka, P. Baum, M. Sergerie, P. Hermann, and G. Delespesse. 1998. OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors. Blood 92: 3338-3345.
26. Gavin, M. A., S. R. Clarke, E. Negrou, A. Gallegos, and A. Rudensky. 2002. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat. Immunol. 3: 33-41.
27. McHugh, R. S., M. J. Whitters, C. A. Piccirillo, D. A. Young, E. M. Shevach, M. Collins, and M. C. Byrne. 2002. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16: 311-323.
28. Yagi, H., Y. Tokura, H. Wakita, F. Furukawa, and M. Takigawa. 1996. TCRV beta 7+ Th2 cells mediate UVB-induced suppression of murine contact photo-sensitivity by releasing IL-10. J. Immunol. 156: 1824-1831.
29. Kabashima, K., T. Murata, H. Tanaka, T. Matsuoka, D. Sakata, N. Yoshida, K. Katagiri, T. Kinashi, T. Tanaka, M. Miyasaka, et al. 2003. Thromboxane A2 modulates interaction of dendritic cells and T cells and regulates acquired immunity. Nat. Immunol. 4: 694-701.
30. Probst, H. C., K. McCoy, T. Okazaki, T. Honjo, and M. van den Broek. 2005. Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4. Nat. Immunol. 6: 280-286.
31. Shevach, E. M. 2002. CD4+ CD25+ suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2: 389-400.
32. Ginhoux, F., M. P. Collin, M. Bogunovic, M. Abel, M. Leboeuf, J. Helft, J. Ochando, A. Kissenpfennig, B. Malissen, M. Grisotto, et al. 2007. Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J. Exp. Med. 204: 3133-3146.
33. Kaplan, D. H., A. Kissenpfennig, and B. E. Clausen. 2008. Insights into Langerhans cell function from Langerhans cell ablation models. Eur. J. Immunol. 38: 2369-2376.
34. Nagao, K., F. Ginhoux, W. W. Leitner, S. Motegi, C. L. Bennett, B. E. Clausen, M. Merad, and M. C. Udey. 2009. Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. Proc. Natl. Acad. Sci. USA 106: 3312-3317.
35. Poulin, L. F., S. Henri, B. de Bovis, E.Devilard, A. Kissenpfennig, and B. Malissen. 2007. The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J. Exp. Med. 204: 3119-3131.
36. Wang, L., L. S. Bursch, A. Kissenpfennig, B. Malissen, S. C. Jameson, and K. A. Hogquist. 2008. Langerin expressing cells promote skin immune responses under defined conditions. J. Immunol. 180: 4722-4727.
37. Kissenpfennig, A., S. Henri, B. Dubois, C. Laplace-Builhé, P. Perrin, N. Romani, C. H. Tripp, P. Douillard, L. Leserman, D. Kaiserlian, et al. 2005. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22: 643-654.
38. Tokura, Y., H. Yagi, H. Hashizume, J. Yagi, F. Furukawa, and M. Takigawa. 1994. Accessory cell ability of Langerhans cells for superantigen is resistant to ultraviolet-B light. Photochem. Photobiol. 60: 147-153.
39. Goldszmid, R. S., J. Idoyaga, A. I. Bravo, R. Steinman, J. Mordoh, and R. Wainstok. 2003. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma. J. Immunol. 171: 5940-5947.
40. Romani, N., S. Holzmann, C. H. Tripp, F. Koch, and P. Stoitzner. 2003. Langerhans cells - dendritic cells of the epidermis. APMIS 111: 725-740.
41. Kaplan, D. H., M. C. Jenison, S. Saeland, W. D. Shlomchik, and M. J. Shlomchik. 2005. Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 23: 611-620.
42. Fukunaga, A., N. M. Khaskhely, C. S. Sreevidya, S. N. Byrne, and S. E. Ullrich. 2008. Dermal dendritic cells, and not Langerhans cells, play an essential role in inducing an immune response. J. Immunol. 180: 3057-3064.
43. Loser, K., A. Mehling, S. Loeser, J. Apelt, A. Kuhn, S. Grabbe, T. Schwarz, J. M. Penninger, and S. Beissert. 2006. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat. Med. 12: 1372-1379.
44. Yoshiki, R., K. Kabashima, K. Sugita, K. Atarashi, T. Shimauchi, and Y. Tokura. 2009. IL-10-producing Langerhans cells and regulatory T cells are responsible for depressed contact hypersensitivity in grafted skin. J. Invest. Dermatol. 129: 705-713.
45. Annacker, O., R. Pimenta-Araujo, O. Burlen-Defranoux, T. C. Barbosa, A. Cumano, and A. Bandeira. 2001. CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol. 166: 3008-3018.
46. Ghoreishi, M., and J. P. Dutz. 2006. Tolerance induction by transcutaneous immunization through ultraviolet-irradiated skin is transferable through CD4+ CD25+ T regulatory cells and is dependent on host-derived IL-10. J. Immunol. 176: 2635-2644. (Pubitemid 43201716)
47. Girolomoni, G., P. Gisondi, C. Ottaviani, and A. Cavani. 2004. Immunoregulation of allergic contact dermatitis. J. Dermatol. 31: 264-270.
48. Enk, A. H., J. Saloga, D. Becker, M. Mohamadzadeh, and J. Knop. 1994. Induction of hapten-specific tolerance by interleukin 10 in vivo. J. Exp. Med. 179: 1397-1402.
49. Niizeki, H., and J. W. Streilein. 1997. Hapten-specific tolerance induced by acute, low-dose ultraviolet B radiation of skin is mediated via interleukin-10. J. Invest. Dermatol. 109: 25-30.
50. Rivas, J. M., and S. E. Ullrich. 1992. Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10. J. Immunol. 149: 3865-3871.
51. Enk, A. H., and S. I. Katz. 1992. Identification and induction of keratinocytederived IL-10. J. Immunol. 149: 92-95.
52. Ullrich, S. E. 1994. Mechanism involved in the systemic suppression of antigenpresenting cell function by UV irradiation. Keratinocyte-derived IL-10 modulates antigen-presenting cell function of splenic adherent cells. J. Immunol. 152: 3410-3416.
53. Akbari, O., R. H. DeKruyff, and D. T. Umetsu. 2001. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat. Immunol. 2: 725-731.
54. Maeda, A., A. Schwarz, K. Kernebeck, N. Gross, Y. Aragane, D. Peritt, and T. Schwarz. 2005. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J. Immunol. 174: 5968-5976.
55. Savill, J., I. Dransfield, C. Gregory, and C. Haslett. 2002. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat. Rev. Immunol. 2: 965-975.
56. Steinman, R. M., D. Hawiger, K. Liu, L. Bonifaz, D. Bonnyay, K. Mahnke, T. Iyoda, J. Ravetch, M. Dhodapkar, K. Inaba, and M. Nussenzweig. 2003. Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann. N. Y. Acad. Sci. 987: 15-25.
57. Higgins, L. M., S. A. McDonald, N. Whittle, N. Crockett, J. G. Shields, and T. T. MacDonald. 1999. Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein. J. Immunol. 162: 486-493.
58. MacPhee, I. A., H. Yagita, and D. B. Oliveira. 2006. Blockade of OX40-ligand after initial triggering of the T helper 2 response inhibits mercuric chloride-induced autoimmunity. Immunology 117: 402-408.
59. Takeda, I., S. Ine, N. Killeen, L. C. Ndhlovu, K. Murata, S. Satomi, K. Sugamura, and N. Ishii. 2004. Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells. J. Immunol. 172: 3580-3589.
60. Wang, L., S. C. Jameson, and K. A. Hogquist. 2009. Epidermal Langerhans cells are not required for UV-induced immunosuppression. J. Immunol. 183: 5548-5553.
61. Aragane,Y.,A.Maeda, A. Schwarz, T. Tezuka, K. Ariizumi, and T. Schwarz. 2003. Involvement of dectin-2 in ultraviolet radiation-induced tolerance. J. Immunol. 171: 3801-3807.
62. Schwarz, A., A. Maeda, M. K. Wild, K. Kernebeck, N. Gross, Y. Aragane, S. Beissert, D. Vestweber, and T. Schwarz. 2004. Ultraviolet radiation-induced regulatory T cells not only inhibit the induction but can suppress the effector phase of contact hypersensitivity. J. Immunol. 172: 1036-1043.
63. Mori, T., K. Kabashima, R. Yoshiki, K. Sugita, N. Shiraishi, A. Onoue, E. Kuroda, M. Kobayashi, U. Yamashita, and Y. Tokura. 2008. Cutaneous hypersensitivities to hapten are controlled by IFN-gamma-upregulated keratinocyte Th1 chemokines and IFN-gamma-downregulated langerhans cell Th2 chemokines. J. Invest. Dermatol. 128: 1719-1727.